Goldsboro Pain Medicine Goldsboro, NC - 27534

Goldsboro Pain Medicine is categorized under Anesthesiologists in Goldsboro, NC and active since 2002.

Goldsboro Pain Medicine was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Anesthesiologists business, which does work in the B2C market, and is classified as a Anesthesiologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jane Price, Office Manager at the company’s single location by writing to 1208 Parkway Drive # C, Goldsboro, North Carolina NC 27534 or by phoning (919) 751-8444. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Goldsboro Pain Medicine
Contact Person: Jane Price, Office Manager
Address: 1208 Parkway Drive # C, Goldsboro, North Carolina 27534
Phone Number: (919) 751-8444
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Anesthesiologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Goldsboro Pain Medicine was started in 2002 to provide professional Anesthesiologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Jane Price, Office Manager for inquiries that concern Goldsboro Pain Medicine by calling the company number (919) 751-8444, as your correspondence is most welcome. Additionally, the physical location of the single location of Goldsboro Pain Medicine can be found at the coordinates 35.38423,-77.93514 as well as the street address 1208 Parkway Drive # C in Goldsboro, North Carolina 27534.

For its online presence, you may visit Goldsboro Pain Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.